The analysis performed 10 days after tumor injection showed that the vast majority (around 80%) of tumor-infiltrating CD4+CD25+ cells derived from expansion/recruitment of the transferred Treg, rather than from conversion of non-Treg. Here, CD4 is linked to neoplasm.